Growth Metrics

Erasca (ERAS) Payables (2020 - 2026)

Erasca posted quarterly Payables of $2.2 million for Q1 2026, down 4.38% year-on-year from $2.3 million in Q1 2025, and up 120.49% on a QoQ basis from $981000.0 in Q4 2025.

Erasca (ERAS) has 7 years of Payables data on file, last reported at $2.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Payables fell 4.38% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 4.38% YoY), and the FY2025 full-year result was $981000.0, up 109.62% from the prior year.
  • Payables for Q1 2026 stood at $2.2 million, up from $981000.0 in the prior quarter.
  • Across five years, Payables topped out at $23.0 million in Q4 2022 and bottomed at $468000.0 in Q4 2024.
  • The 5-year median for Payables is $2.4 million (2024), against an average of $3.8 million.
  • The widest annual swing landed in 2022, when Payables soared 392.82%; it then plunged 91.32% in 2023.
  • A 5-year view of Payables shows it stood at $23.0 million in 2022, then slumped by 91.32% to $2.0 million in 2023, then plunged by 76.6% to $468000.0 in 2024, then jumped by 109.62% to $981000.0 in 2025, then surged by 120.49% to $2.2 million in 2026.
  • The last three Payables figures came in at $2.2 million (Q1 2026), $981000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 300,549.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.69 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 Erasca 4.21 Bn 3.97 Bn - 2.16 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.16 Mn
Dec 31, 2025 981,000.00
Sep 30, 2025 3.03 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 2.26 Mn
Dec 31, 2024 468,000.00
Sep 30, 2024 2.41 Mn
Jun 30, 2024 2.14 Mn
Mar 31, 2024 2.63 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 3.70 Mn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 3.35 Mn
Dec 31, 2022 23.05 Mn
Sep 30, 2022 4.32 Mn
Jun 30, 2022 2.29 Mn
Mar 31, 2022 4.71 Mn
Dec 31, 2021 4.68 Mn
Sep 30, 2021 1.32 Mn
Jun 30, 2021 1.51 Mn
Dec 31, 2020 878,000.00